Introduction: Patients with congenital hyperinsulinism (HI) require constant glucose
monitoring to detect and treat recurrent and severe hypoglycemia. Historically, this has been …

Background: Effective treatment and close monitoring in children with congenital
hyperinsulinism (HI) are important to prevent hypoglycemic-associated brain damage. The …

Background and Aims In patients with congenital hyperinsulinism (CHI), recurrent
hypoglycaemia can lead to longstanding neurological impairments. At present, glycaemic …

Objectives Unrecognized hypoglycemia, especially in the neonatal population, is a
significant cause of morbidity and poor neurologic outcomes. Children with congenital …

Objectives Glucose monitoring is vital in children with persistent hypoglycaemia to reduce
the risk of adverse neuro-behavioural outcomes; especially in children with hyperinsulinism …

Background Persistent hypoglycemia is common in the newborn and is associated with poor
neurodevelopmental outcome. Adequate monitoring is critical in prevention, but is …

Introduction Hypoglycemia is often recurrent and severe in patients with congenital
hyperinsulinism (CHI). However, there is little information regarding frequency or patterns of …

Blood glucose monitoring is a way of testing the concentration of glucose in the blood. The
most recent advance is the development of continuous glucose monitoring system (CGMS) …

Abstract Background The factory calibrated FreeStyle Libre (FSL) flash glucose monitoring
system has been recently introduced for use in patients with diabetes mellitus. There are no …

Glucose is the primary oxidative fuel for the brain. A recent analysis combining PET (positron
emission tomography) and MRI (magnet resonance imaging) data to calculate the human …